• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21959 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2003     NIHR Horizon Scanning Centre (NIHR HSC) Oblimersen for advanced malignant melanoma and refractory chronic lymphocytic leukaemia - horizon scanning review
2005     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for non-small cell lung cancer (nsclc) - horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Dapagliflozin (BMS 512148) for type 2 diabetes mellitus - add on therapy
2010     NIHR Horizon Scanning Centre (NIHR HSC) Vorapaxar for secondary prevention of cardiovascular events
2011     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for triple negative adjuvant breast cancer; in combination with taxane and/or anthracycline chemotherapy
2014     NIHR Horizon Scanning Centre (NIHR HSC) Pertuzumab (Perjeta) for HER2-positive locally advanced, inflammatory or early breast cancer – neo-adjuvant in combination with trastuzumab and docetaxel
2015     NIHR Horizon Scanning Centre (NIHR HSC) CoSense® End Tidal Carbon Monoxide monitor for neonatal haemolytic disease
2016     NIHR Horizon Scanning Centre (NIHR HSC) Cytovir CMV for cytomegalovirus infection in patients undergoing allogeneic haematopoietic stem cell transplantation
2016     NIHR Horizon Scanning Centre (NIHR HSC) Naloxone single dose nasal spray for opioid overdose
2003     NIHR Horizon Scanning Centre (NIHR HSC) Oncophage for renal cell carcinoma and malignant melanoma - horizon scanning review
2005     NIHR Horizon Scanning Centre (NIHR HSC) Certolizumab pegol (Cimzia) for rheumatoid arthritis - horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib plus paclitaxel for metastatic breast cancer - first line
2010     NIHR Horizon Scanning Centre (NIHR HSC) Zoledronic acid (Zometa) for hormone-receptor-positive early breast cancer - adjuvant therapy
2011     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) with octreotide (Sandostatin) for high risk carcinoid tumours – first or second line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Pacritinib for myelofibrosis
2014     NIHR Horizon Scanning Centre (NIHR HSC) SoftVue™ system for diagnostic breast imaging
2016     NIHR Horizon Scanning Centre (NIHR HSC) Lenvatinib in combination with everolimus for advanced or metastatic renal cell carcinoma – second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) RGN-259 for neurotrophic keratopathy
2003     NIHR Horizon Scanning Centre (NIHR HSC) Opto-electronic low vision aids for the visually impaired - horizon scanning review
2005     NIHR Horizon Scanning Centre (NIHR HSC) Duloxetine for fibromyalgia - horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Rivaroxaban (Xarelto) for venous thromboembolism
2010     NIHR Horizon Scanning Centre (NIHR HSC) Conestat alfa (Ruconest) for acute hereditary angioedema
2014     NIHR Horizon Scanning Centre (NIHR HSC) Paclitaxel poliglumex (Xyotax) for advanced ovarian cancer – maintenance therapy
2015     NIHR Horizon Scanning Centre (NIHR HSC) Idarucizumab for the reversal of anticoagulation due to treatment with dabigatran – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for follicular non-Hodgkin lymphoma ─ third line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Botulinum toxin A (Dysport) for hyperhidrosis of the axillae
2003     NIHR Horizon Scanning Centre (NIHR HSC) Ruboxistaurin for diabetic neuropathy - horizon scanning review
2005     NIHR Horizon Scanning Centre (NIHR HSC) Infliximab (Remicade) for ulcerative colitis - horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Sunitinib for advanced and/or metastatic pancreatic neuroendocrine tumours
2010     NIHR Horizon Scanning Centre (NIHR HSC) Abiraterone acetate for metastatic, castration-resistant prostate cancer
2014     NIHR Horizon Scanning Centre (NIHR HSC) Necitumumab in combination with gemcitabine and cisplatin for advanced and metastatic non-small cell lung cancer – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Asunaprevir, beclabuvir and daclatasvir fixed dose combination for hepatitis C virus infection, genotype 1 – first or second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Ibrutinib (Imbruvica) with bendamustine and rituximab for chronic lymphocytic leukaemia or small lymphocytic lymphoma – second line
2003     NIHR Horizon Scanning Centre (NIHR HSC) Strontium ranelate for osteoporosis - horizon scanning review
2005     NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib (GW572016) for advanced or metastatic breast cancer - horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Ustekinumab (Stelara) for psoriatic arthritis - second line after disease modifying anti-rheumatic drugs (DMARDs)
2010     NIHR Horizon Scanning Centre (NIHR HSC) AIN457 for Behcet's related uveitis - second line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Midostaurin for newly diagnosed FLT3-mutated acute myeloid leukaemia – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir (Sovaldi) with GS-5816 for chronic hepatitis C
2016     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for metastatic or unresectable urothelial bladder cancer – second line
2003     NIHR Horizon Scanning Centre (NIHR HSC) Trabectedin for soft tissue sarcoma - horizon scanning review
2005     NIHR Horizon Scanning Centre (NIHR HSC) Lenalidomide (Revlimid) for low- and intermediate-1-risk myelodysplastic syndromes with deletion 5q chromosomal abnormality - horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Vorinostat for refractory multiple myeloma
2010     NIHR Horizon Scanning Centre (NIHR HSC) B-cell lymphoma vaccine (BiovaxID) for follicular non-Hodgkin's lymphoma
2012     NIHR Horizon Scanning Centre (NIHR HSC) Sebelipase alfa for lysosomal acid lipase deficiency
2014     NIHR Horizon Scanning Centre (NIHR HSC) Custirsen for locally advanced or metastatic hormone-relapsed prostate cancer – first and second line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Collagenase Clostridium histolyticum (Xiapex) for Peyronie's disease – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Obinutuzumab (Gazyvaro) with bendamustine for chronic lymphocytic leukaemia ─ first line
2005     NIHR Horizon Scanning Centre (NIHR HSC) Lenalidomide (Revlimid) for relapsed and/or refractory multiple myeloma - horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Boceprevir for hepatitis C
2011     NIHR Horizon Scanning Centre (NIHR HSC) Cetuximab (Erbitux) in combination with oxaliplatin, leucovorin and fluorouracil for colorectal cancer - adjuvant
2014     NIHR Horizon Scanning Centre (NIHR HSC) Lumacaftor and ivacaftor combination therapy for cystic fibrosis – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Epratuzumab for systemic lupus erythematosus
2016     NIHR Horizon Scanning Centre (NIHR HSC) LentiGlobin BB305 (LentiGlobin) for beta-thalassaemia major – first line
2005     NIHR Horizon Scanning Centre (NIHR HSC) NIOX MINO airway inflammation monitor for the diagnosis and monitoring of asthma - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Ethyl-EPA (Miraxion) for Huntington's Disease: horizon scanning technology briefing
2010     NIHR Horizon Scanning Centre (NIHR HSC) Bosutinib for chronic myeloid leukaemia - first/second line
2011     NIHR Horizon Scanning Centre (NIHR HSC) Brivanib for hepatocellular carcinoma – second line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Velcalcetide for secondary hyperparathyroidism – first line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Spheroids of human autologous matrix-associated chondrocytes (Chondrosphere) for articular cartilage defects
2016     NIHR Horizon Scanning Centre (NIHR HSC) Ibrutinib (Imbruvica) with R-CHOP for diffuse large B-cell lymphoma – first line
2005     NIHR Horizon Scanning Centre (NIHR HSC) Non-invasive bladder function test (penile cuff test, CT3000) for men with lower urinary tract symptoms - horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Botulinum toxin type A (Botox) for chronic migraine
2011     NIHR Horizon Scanning Centre (NIHR HSC) Cetuximab (Erbitux) in combination with capecitabine and cisplatin for advanced or metastatic gastric cancer – first line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Autologous Muscle Derived Cells-Urethral Sphincter Repair (AMDC-USR) for stress urinary incontinence
2014     NIHR Horizon Scanning Centre (NIHR HSC) Alpha-1 antitrypsin (Respreeza) for emphysema associated with alpha-1 antitrypsin deficiency – maintenance therapy
2016     NIHR Horizon Scanning Centre (NIHR HSC) Afatinib (Giotrif) for advanced or metastatic, squamous non-small cell lung cancer progressing on or after platinum-based chemotherapy
2005     NIHR Horizon Scanning Centre (NIHR HSC) Perioperative chemotherapy for operable gastro-oesophageal cancer - horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Iniparib for triple negative metastatic breast cancer - first, second or third line
2011     NIHR Horizon Scanning Centre (NIHR HSC) Dasatinib (Sprycel) for prostate cancer – in combination with docetaxel
2014     NIHR Horizon Scanning Centre (NIHR HSC) Purified botulinum toxin type A (Botox) for post-stroke lower limb spasticity
2014     NIHR Horizon Scanning Centre (NIHR HSC) Adalimumab (Humira) for severe chronic plaque psoriasis in children and adolescents – second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Triptorelin (Decapeptyl SR) for premenopausal women with early endocrine responsive breast cancer
2005     NIHR Horizon Scanning Centre (NIHR HSC) Thymalfasin (Zadaxin) for hepatitis C virus - horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Canakinumab (Ilaris) for treatment of acute gout flares
2011     NIHR Horizon Scanning Centre (NIHR HSC) EC145 for folate receptor positive ovarian cancer
2014     NIHR Horizon Scanning Centre (NIHR HSC) Tocilizumab (RoACTEMRA) for giant cell arteritis – first and second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Pegpleranib (Fovista) for neovascular age-related macular degeneration
2010     NIHR Horizon Scanning Centre (NIHR HSC) Canakinumab for systemic juvenile idiopathic arthritis
2011     NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) in combination with sorafenib (Nexavar) for unresectable, advanced or metastatic hepatocellular carcinoma – first line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ramucirumab in combination with paclitaxel for advanced gastric cancer and gastro-oesophageal junction adenocarcinoma after prior chemotherapy
2016     NIHR Horizon Scanning Centre (NIHR HSC) Idebenone (Raxone) for Duchenne muscular dystrophy – first line
2010     NIHR Horizon Scanning Centre (NIHR HSC) Eicosapentaenoic acid for familial adenomatous polyposis
2011     NIHR Horizon Scanning Centre (NIHR HSC) Heat-activated liposome encapsulated doxorubicin (ThermoDox) for hepatocellular carcinoma – first line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Onartuzumab for metastatic Met positive gastric or gastro-oesophageal junction cancer
2016     NIHR Horizon Scanning Centre (NIHR HSC) Ibrutinib (Imbruvica) for relapsed and refractory marginal zone lymphoma – second or subsequent line
2010     NIHR Horizon Scanning Centre (NIHR HSC) Fampridine-PR for multiple sclerosis: impaired mobility - first line
2011     NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (Yervoy) for prostate cancer – second line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Obinutuzumab in combination with CHOP chemotherapy for CD20-positive diffuse large B-cell lymphoma – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Binimetinib for recurrent or persistent ovarian, fallopian tube or primary peritoneal cancer ─ second and subsequent line
2010     NIHR Horizon Scanning Centre (NIHR HSC) GDC-0449 for advanced basal cell carcinoma - first or second line
2011     NIHR Horizon Scanning Centre (NIHR HSC) Masitinib with gemcitabine for advanced or metastatic pancreatic cancer
2012     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) for mucopolysaccharidosis type IVA – first line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Obinutuzumab in combination with bendamustine for rituximab-refractory indolent non-Hodgkin's lymphoma – second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Pexiganan (Locilex) for mild foot infection in diabetic foot ulcers
2005     NIHR Horizon Scanning Centre (NIHR HSC) FibroTest-ActiTest for diagnosis and monitoring of fibrosis in chronic liver conditions - horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Modified-release hydrocortisone (DuoCort) for adrenal insufficiency
2011     NIHR Horizon Scanning Centre (NIHR HSC) Paclitaxel (Paclical) for epithelial ovarian cancer, fallopian tube cancer or peritoneal cancer – second or third line
2012     NIHR Horizon Scanning Centre (NIHR HSC) Fostamatinib for rheumatoid arthritis – second line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ixazomib citrate for relapsed and/or refractory multiple myeloma